<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><link type="text/css" rel="stylesheet" href="resources/sheet.css" >
<style type="text/css">.ritz .waffle a { color: inherit; }.ritz .waffle .s0{background-color:#ffffff;text-align:left;color:#000000;font-family:Arial;font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s1{border-right:none;background-color:#ffffff;text-align:left;color:#000000;font-family:Arial;font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}</style><div class="ritz grid-container" dir="ltr"><table class="waffle" cellspacing="0" cellpadding="0"><thead><tr><th class="row-header freezebar-origin-ltr"></th><th id="569039987C0" style="width:100px;" class="column-headers-background">A</th><th id="569039987C1" style="width:100px;" class="column-headers-background">B</th><th id="569039987C2" style="width:100px;" class="column-headers-background">C</th><th id="569039987C3" style="width:308px;" class="column-headers-background">D</th><th id="569039987C4" style="width:100px;" class="column-headers-background">E</th><th id="569039987C5" style="width:100px;" class="column-headers-background">F</th></tr></thead><tbody><tr style="height: 20px"><th id="569039987R0" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">1</div></th><td class="s0" dir="ltr">Theme</td><td class="s0" dir="ltr">Time</td><td class="s0" dir="ltr">Venue</td><td class="s0" dir="ltr">Speaker</td><td class="s0" dir="ltr">Session</td><td class="s0" dir="ltr">Session Time</td></tr><tr style="height: 20px"><th id="569039987R1" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">2</div></th><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Opening Session</div></td><td class="s0" dir="ltr">08:00–08:45</td><td class="s0" dir="ltr">Grand Ballroom</td><td class="s0" dir="ltr">Malvina EYDELMAN (U.S.)</td><td class="s0" dir="ltr">08:00–08:10</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Welcome &amp; Introductory Remarks</div></td></tr><tr style="height: 20px"><th id="569039987R2" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">3</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Mark BLUMENKRANZ (U.S.)</td><td class="s0" dir="ltr">08:10–08:30</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">Keynote Lecture 1: The Role of Academic, Industrial and Governmental Collaboration...</div></td></tr><tr style="height: 20px"><th id="569039987R3" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">4</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Emmett CUNNINGHAM (U.S.)</td><td class="s0" dir="ltr">08:30–08:45</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">The OIS Story: How a Bold Idea Transformed the U.S. Startup Landscape</div></td></tr><tr style="height: 20px"><th id="569039987R4" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">5</div></th><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Session 1: Defining the Future – Establishing Standard Terminology &amp; Endpoints for Oculomics</div></td><td class="s0" dir="ltr">08:50–10:40</td><td class="s0" dir="ltr">Grand Ballroom</td><td class="s0" dir="ltr">Alvin LIU (U.S.)</td><td class="s0" dir="ltr">08:50–08:58</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Why Do We Need to Define Standards for Oculomics?</div></td></tr><tr style="height: 20px"><th id="569039987R5" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">6</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Cecilia LEE (U.S.)</td><td class="s0" dir="ltr">08:58–09:06</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">Oculomics as Pre-Screening, Screening, or Opportunistic Screening Tool?</div></td></tr><tr style="height: 20px"><th id="569039987R6" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">7</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Daniela FERRARA (U.S.)</td><td class="s0" dir="ltr">09:06–09:14</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">Oculomics Research for Systemic Disease Prediction: Ophthalmology at the Center of Healthcare</div></td></tr><tr style="height: 20px"><th id="569039987R7" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">8</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Vincent MOK (Hong Kong)</td><td class="s0" dir="ltr">09:14–09:22</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Case Study – Endpoints of Brain Health</div></td></tr><tr style="height: 20px"><th id="569039987R8" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">9</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Tyler RIM (South Korea)</td><td class="s0" dir="ltr">09:22–09:30</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Case Study – Endpoints of Cardiovascular Risk</div></td></tr><tr style="height: 20px"><th id="569039987R9" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">10</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Tien WONG (China)</td><td class="s0" dir="ltr">09:30–09:38</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">What Should the Oculomics Ecosystem Look Like?</div></td></tr><tr style="height: 20px"><th id="569039987R10" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">11</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Malvina EYDELMAN (U.S.)</td><td class="s0" dir="ltr">09:38–09:46</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Regulatory Pathway for Oculomics</div></td></tr><tr style="height: 20px"><th id="569039987R11" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">12</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Ryo KAWASAKI (Japan)</td><td class="s0" dir="ltr">09:46–09:54</td><td class="s0" dir="ltr">TBC</td></tr><tr style="height: 20px"><th id="569039987R12" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">13</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Leanne LABRIOLA (U.S.)</td><td class="s0" dir="ltr">09:54–10:02</td><td class="s0" dir="ltr">TBC</td></tr><tr style="height: 20px"><th id="569039987R13" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">14</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Vinit MAHAJAN (U.S.)</td><td class="s0" dir="ltr">10:02–10:10</td><td class="s0" dir="ltr">TBC</td></tr><tr style="height: 20px"><th id="569039987R14" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">15</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Michael MCCONNELL (U.S.)</td><td class="s0" dir="ltr">10:10–10:18</td><td class="s0" dir="ltr">TBC</td></tr><tr style="height: 20px"><th id="569039987R15" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">16</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Lisa ZHU (Australia)</td><td class="s0" dir="ltr">10:18–10:26</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Oculomics for Diabetes Complications</div></td></tr><tr style="height: 20px"><th id="569039987R16" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">17</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Panelists</td><td class="s0" dir="ltr">10:26–10:50</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Panel Discussion</div></td></tr><tr style="height: 20px"><th id="569039987R17" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">18</div></th><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Session 2: Glaucoma Innovation</div></td><td class="s0" dir="ltr">11:15–12:40</td><td class="s0" dir="ltr">Grand Ballroom</td><td class="s0" dir="ltr">Donald C. HOOD (U.S.)</td><td class="s0" dir="ltr">11:15–11:23</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">A Pattern-Based OCT Metric for Glaucoma Detection Outperforms Conventional Metrics</div></td></tr><tr style="height: 20px"><th id="569039987R18" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">19</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Philippe ANDREUCCI (France)</td><td class="s0" dir="ltr">11:23–11:31</td><td class="s0" dir="ltr">Microbattery</td></tr><tr style="height: 20px"><th id="569039987R19" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">20</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Ki Ho PARK (South Korea)</td><td class="s0" dir="ltr">11:31–11:39</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">New Frontiers in Glaucoma Diagnosis &amp; Management</div></td></tr><tr style="height: 20px"><th id="569039987R20" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">21</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Kfir AZOULAY (Germany)</td><td class="s0" dir="ltr">11:39–11:47</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">What Industry Must Do Now to Transform Glaucoma’s Trajectory</div></td></tr><tr style="height: 20px"><th id="569039987R21" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">22</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Ariel CAO (U.S.)</td><td class="s0" dir="ltr">11:47–11:55</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Innovation in Intraocular Pressure Sensors</div></td></tr><tr style="height: 20px"><th id="569039987R22" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">23</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Chris LEUNG (Hong Kong)</td><td class="s0" dir="ltr">11:55–12:03</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Summary from the SIGMA Summit</div></td></tr><tr style="height: 20px"><th id="569039987R23" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">24</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Gopalan BALAJI (U.S.)</td><td class="s0" dir="ltr">12:03–12:11</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">Gore GDI – Device Design, Materials of Construction and their Influence on Clinical Results</div></td></tr><tr style="height: 20px"><th id="569039987R24" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">25</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">George KONG (Australia)</td><td class="s0" dir="ltr">12:11–12:19</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Innovating Glaucoma Visual Field Testing...</div></td></tr><tr style="height: 20px"><th id="569039987R25" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">26</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Panelists</td><td class="s0" dir="ltr">12:19–12:40</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Panel Discussion</div></td></tr><tr style="height: 20px"><th id="569039987R26" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">27</div></th><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Session 3: AI at the Frontline of Ophthalmic Innovation</div></td><td class="s0" dir="ltr">11:15–12:40</td><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Grand III, IV &amp; Annex</div></td><td class="s0" dir="ltr">Paisan RUAMVIBOONSUK (Thailand)</td><td class="s0" dir="ltr">11:15–11:23</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">AI and Population Eye Screening – Lessons from Thailand</div></td></tr><tr style="height: 20px"><th id="569039987R27" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">28</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Olga PRENAT (France)</td><td class="s0" dir="ltr">11:23–11:31</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">From Frames to Intelligence: The New Era of AI-Enhanced Wearables</div></td></tr><tr style="height: 20px"><th id="569039987R28" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">29</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Paul CHAN (U.S.)</td><td class="s0" dir="ltr">11:31–11:39</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Using AI to Change Clinical Flow &amp; Optimize Efficiency</div></td></tr><tr style="height: 20px"><th id="569039987R29" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">30</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Donald C. HOOD (U.S.)</td><td class="s0" dir="ltr">11:39–11:47</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">A Deep Learning Model for Glaucoma Detection Outperforms Conventional Metrics</div></td></tr><tr style="height: 20px"><th id="569039987R30" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">31</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Zhen TIAN (Hong Kong)</td><td class="s0" dir="ltr">11:47–11:55</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Virtual Spectacle Try-On: How Real It Could Be?</div></td></tr><tr style="height: 20px"><th id="569039987R31" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">32</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Anand SIVARAMAN (India)</td><td class="s0" dir="ltr">11:55–12:03</td><td class="s0" dir="ltr">TBC</td></tr><tr style="height: 20px"><th id="569039987R32" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">33</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Mingguang HE (Hong Kong)</td><td class="s0" dir="ltr">12:03–12:11</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">What’s Next When We Are Able to Generate FFA?</div></td></tr><tr style="height: 20px"><th id="569039987R33" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">34</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Jovian WEE (Singapore)</td><td class="s0" dir="ltr">12:11–12:19</td><td class="s0" dir="ltr">TBC</td></tr><tr style="height: 20px"><th id="569039987R34" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">35</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Panelists</td><td class="s0" dir="ltr">12:19–12:40</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Panel Discussion</div></td></tr><tr style="height: 20px"><th id="569039987R35" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">36</div></th><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Alcon-Sponsored Lunch Symposium</div></td><td class="s0" dir="ltr">12:40–13:40</td><td class="s0" dir="ltr">Grand Ballroom</td><td class="s0" dir="ltr">-</td><td class="s0" dir="ltr">12:40–13:40</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Lunch Symposium</div></td></tr><tr style="height: 20px"><th id="569039987R36" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">37</div></th><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Keynote Session &amp; Fireside Chats</div></td><td class="s0" dir="ltr">13:40–15:30</td><td class="s0" dir="ltr">Grand Ballroom</td><td class="s0" dir="ltr">Hugh TAYLOR (Australia)</td><td class="s0" dir="ltr">13:40–14:00</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">Keynote Lecture 2: Opening Eyes: From Discovery to Delivery of Vision Care</div></td></tr><tr style="height: 20px"><th id="569039987R37" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">38</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Neil BRESSLER (U.S.)</td><td class="s0" dir="ltr">14:00–14:20</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">Keynote Lecture 3: JAMA Ophthalmology’s Global Role in Accelerating Innovation</div></td></tr><tr style="height: 20px"><th id="569039987R38" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">39</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Robert LEVINE (U.S.)</td><td class="s0" dir="ltr">14:20–14:40</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Keynote Lecture 4: DRD Cure Accelerator</div></td></tr><tr style="height: 20px"><th id="569039987R39" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">40</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Hosts &amp; Guests</td><td class="s0" dir="ltr">14:40–15:30</td><td class="s0" dir="ltr">Fireside Chats</td></tr><tr style="height: 20px"><th id="569039987R40" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">41</div></th><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Session 4: Anterior Segment – Innovation &amp; Regenerative Medicine</div></td><td class="s0" dir="ltr">15:30–17:00</td><td class="s0" dir="ltr">Grand Ballroom</td><td class="s0" dir="ltr">Natalie AFSHARI (U.S.)</td><td class="s0" dir="ltr">15:30–15:38</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Emerging Technologies in Corneal &amp; Cataract Surgery</div></td></tr><tr style="height: 20px"><th id="569039987R41" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">42</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Kohji NISHIDA (Japan)</td><td class="s0" dir="ltr">15:38–15:46</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Corneal Regenerative Medicine – From Lab to Clinic</div></td></tr><tr style="height: 20px"><th id="569039987R42" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">43</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Nahum FERERA (Israel)</td><td class="s0" dir="ltr">15:46–15:54</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">EndoArt®: Redefining Corneal Edema Care</div></td></tr><tr style="height: 20px"><th id="569039987R43" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">44</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Shigeru KINOSHITA (Japan)</td><td class="s0" dir="ltr">15:54–16:02</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Cell-Based Therapies for Corneal Disease</div></td></tr><tr style="height: 20px"><th id="569039987R44" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">45</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Jonghaw JUN (South Korea)</td><td class="s0" dir="ltr">16:02–16:10</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Innovations in Anterior Segment Surgery</div></td></tr><tr style="height: 20px"><th id="569039987R45" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">46</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Ying JIE (China)</td><td class="s0" dir="ltr">16:10–16:18</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Novel Approaches in Corneal Repair</div></td></tr><tr style="height: 20px"><th id="569039987R46" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">47</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Anuraag SINGH (U.S.)</td><td class="s0" dir="ltr">16:18–16:26</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">Device Design, Materials of Construction, and Their Contribution to Improved Clinical Outcomes</div></td></tr><tr style="height: 20px"><th id="569039987R47" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">48</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Jod MEHTA (Singapore)</td><td class="s0" dir="ltr">16:26–16:34</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Updates on Cornea &amp; Refractive Laser</div></td></tr><tr style="height: 20px"><th id="569039987R48" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">49</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Amar AGARWAL (India)</td><td class="s0" dir="ltr">16:34–16:42</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Complex Anterior Segment Cases – Pearls &amp; Pitfalls</div></td></tr><tr style="height: 20px"><th id="569039987R49" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">50</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Panelists</td><td class="s0" dir="ltr">16:42–17:00</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Panel Discussion</div></td></tr><tr style="height: 20px"><th id="569039987R50" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">51</div></th><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Session 5: Imaging Innovation</div></td><td class="s0" dir="ltr">15:30–16:30</td><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Grand III, IV &amp; Annex</div></td><td class="s0" dir="ltr">Ashley KRAS (Australia)</td><td class="s0" dir="ltr">15:30–15:38</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Imaging in Complex Retinal Disease – What Are We Still Missing?</div></td></tr><tr style="height: 20px"><th id="569039987R51" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">52</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Chris LEUNG (Hong Kong)</td><td class="s0" dir="ltr">15:38–15:46</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">AI-Powered Imaging for Glaucoma Screening at Scale: The HKU × Orbis ROTA Experience</div></td></tr><tr style="height: 20px"><th id="569039987R52" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">53</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Caroline BAUMAL (U.S.)</td><td class="s0" dir="ltr">15:46–15:54</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Imaging-Guided Therapy in Retinal Disease</div></td></tr><tr style="height: 20px"><th id="569039987R53" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">54</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Daniela FERRARA (U.S.)</td><td class="s0" dir="ltr">15:54–16:02</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Imaging Endpoints in Clinical Trials – Where Are We Heading?</div></td></tr><tr style="height: 20px"><th id="569039987R54" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">55</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Eisuke SHIMIZU (Japan)</td><td class="s0" dir="ltr">16:02–16:10</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">AI/Imaging Startups: From Prototype to Practice</div></td></tr><tr style="height: 20px"><th id="569039987R55" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">56</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Panelists</td><td class="s0" dir="ltr">16:10–16:30</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Panel Discussion</div></td></tr><tr style="height: 20px"><th id="569039987R56" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">57</div></th><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Session 6: Retina Innovation</div></td><td class="s0" dir="ltr">17:30–18:40</td><td class="s0" dir="ltr">Grand Ballroom</td><td class="s0" dir="ltr">Tien WONG (China)</td><td class="s0" dir="ltr">17:30–17:38</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">Retinal Innovation in China: Observations, Challenges and Opportunities</div></td></tr><tr style="height: 20px"><th id="569039987R57" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">58</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Remko BAKKER (Germany)</td><td class="s0" dir="ltr">17:38–17:46</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Shaping Eye Health Strategy – A Pharma Perspective</div></td></tr><tr style="height: 20px"><th id="569039987R58" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">59</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Greg KUNST (U.S.)</td><td class="s0" dir="ltr">17:46–17:54</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">Long-Acting Anti-VEGFs, the Future Standard of Care in Retinal Disease</div></td></tr><tr style="height: 20px"><th id="569039987R59" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">60</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Sri MUDUMBA (U.S.)</td><td class="s0" dir="ltr">17:54–18:02</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Interventional Trials across Both IRDs</div></td></tr><tr style="height: 20px"><th id="569039987R60" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">61</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Michael SINGER (U.S.)</td><td class="s0" dir="ltr">18:02–18:10</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Clinical Trial Innovation</div></td></tr><tr style="height: 20px"><th id="569039987R61" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">62</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Stela VUJOSEVIC (Italy)</td><td class="s0" dir="ltr">18:10–18:18</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">AI in AMD and DME Trials</div></td></tr><tr style="height: 20px"><th id="569039987R62" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">63</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Roomasa CHANNA (U.S.)</td><td class="s0" dir="ltr">18:18–18:26</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Global Benchmark for AMD Algorithm Validation</div></td></tr><tr style="height: 20px"><th id="569039987R63" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">64</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Omer TRIVIZKI (Israel)</td><td class="s0" dir="ltr">18:26–18:34</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Setting Standards for AI in Retinal Imaging...</div></td></tr><tr style="height: 20px"><th id="569039987R64" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">65</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Panelists</td><td class="s0" dir="ltr">18:34–18:50</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Panel Discussion</div></td></tr><tr style="height: 20px"><th id="569039987R65" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">66</div></th><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Session 7: Robotics Innovation</div></td><td class="s0" dir="ltr">17:30–18:40</td><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:97px;left:-1px">Grand III, IV &amp; Annex</div></td><td class="s0" dir="ltr">Marc D. de SMET (Switzerland)</td><td class="s0" dir="ltr">17:30–17:38</td><td class="s0" dir="ltr">TBC</td></tr><tr style="height: 20px"><th id="569039987R66" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">67</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Binita ASHAR (U.S.)</td><td class="s0" dir="ltr">17:38–17:46</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Regulatory Considerations for Robotic Surgical Systems</div></td></tr><tr style="height: 20px"><th id="569039987R67" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">68</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Haotian LIN (China)</td><td class="s0" dir="ltr">17:46–17:54</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Robotics and Automation in Ophthalmic Care Pathways</div></td></tr><tr style="height: 20px"><th id="569039987R68" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">69</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">David CHANG (U.S.)</td><td class="s0" dir="ltr">17:54–18:02</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Robotic Cataract Surgery – Threat or Remedy?</div></td></tr><tr style="height: 20px"><th id="569039987R69" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">70</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Koh-Hei SONODA (Japan)</td><td class="s0" dir="ltr">18:02–18:10</td><td class="s0" dir="ltr">TBC</td></tr><tr style="height: 20px"><th id="569039987R70" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">71</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Stephen MCLEOD (U.S.)</td><td class="s0" dir="ltr">18:10–18:18</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Robotic Innovation in Ophthalmology</div></td></tr><tr style="height: 20px"><th id="569039987R71" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">72</div></th><td></td><td></td><td></td><td class="s0" dir="ltr">Panelists</td><td class="s0" dir="ltr">18:18–18:40</td><td class="s1 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Panel Discussion</div></td></tr><tr style="height: 20px"><th id="569039987R72" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">73</div></th><td class="s0" dir="ltr">Closing</td><td class="s0" dir="ltr">18:50–19:00</td><td class="s0" dir="ltr">Grand Ballroom</td><td class="s0" dir="ltr">Malvina EYDELMAN (U.S.)</td><td class="s0" dir="ltr">18:50–19:00</td><td class="s0" dir="ltr">Closing Remarks</td></tr></tbody></table></div>